Allergy and anaphylaxis concerns about COVID-19 vaccines

Allergy and anaphylaxis concerns about COVID-19 vaccines

The webinar on 28 April 2021 focuses on:

  • Risks of allergies / anaphylaxis to these vaccines from studies
  • Recognizing anaphylaxis
  • Setting up your vaccination centre to prepare for anaphylaxis
  • Quick overview of management of anaphylaxis


Prof. Dr. Ammu K Radhakrishnan is a Professor in Immunology at the Jeffrey Cheah School of Medicine and Health Sciences at Monash University Malaysia. Prof. Dr. Ammu obtained her Bachelor of Science (Hons) and Master of Science degrees in Biochemistry from University Malaya and her PhD in Therapeutic Immunology the University of Cambridge, UK. She also undertook two-years of post-doctoral studies after completing her PhD at the University of Oxford, UK. Her main area of research is developing immune-therapeutics to boost host immune system to fight cancer, infections and other immune-related disorders.

Panellists for this week:

Dr. Tang Min Moon is a consultant dermatologist in Kuala Lumpur Hospital. She has more than 13 years of experience in the dermatology field. She also had her fellowship training in National Skin Center Singapore and Inselspital, Bern University Hospital, Bern, Switzerland. Her area of special interest are drug allergy, immunobullous disease and contact dermatitis. She is also the appointed member in the Malaysian Adverse Drug Reactions Advisory Committee, National Pharmaceutical Regulatory Agency, Ministry of Health, Malaysia.

Dr. Soo Kok Foong is an Emergency Medicine Physician working in Sungai Buloh Hospital. He has special interest in disaster management and advanced life support in various situations including aquatic life support. He also a facilitator for basic point of care ultrasound and facilitated numerous emergency medicine workshops in district and state level.

Dr. Mohammed Faizal Bakhtiar is a Physician Scientist working in Allergy & Immunology
Research Center, Institute for Medical Research which is part of National Institutes of Health Malaysia. He has 11 years of experience in allergy and immunology field. His area of expertise is in drug hypersensitivity. He is also a member of a various international allergy and clinical immunology organizations.

Please type your questions below in Slido.

COVID-19 Webinar Series Feedback Survey

Thank you for attending our webinar! We would love to invite you to join our survey study on Health Care Providers' Evaluation of the Weekly "Webinar Series On COVID-19" For Continuing Medical Education (CME). We would like to hear your feedback about this webinar series. Here is the link

P/S: You will be awarded with a research participation certificate upon completion which you can use for your LNPT/SKT/work appraisal etc.

How to join the webinar?

No need to register. Just come to this webpage on Wednesday, 28th April 2021 at 3 PM (GMT+8) to join the live session. You can ask questions directly in this webpage using Slido.

There are other ways to watch the webinar live. You can join us live using your preferred social media account or one of the options below. Don't forget to use to ask questions. As usual our event code is #hcsmMY

How to get CPD points?

We will broadcast the online attendance form during the live webinar, and we will broadcast the attendance form after the webinar finished for another 5 minutes. The link will also be posted on our Twitter, Facebook, LinkedIn and YouTube. Please double-check your email address before submitting. Any mistake in your email address, you will not get the certificate of attendance.

The certificate of attendance is issued to those who participated live (in real-time). We do not give a certificate to those watching the replay/recorded video/podcast.

Looking forward to seeing you live!


If you need more information about this season 2 webinar: the weekly CME programme, CPD point and other info, please go to this webpage:

This is a weekly live webinar jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), National Institutes of Health (NIH) Malaysia.